Amneal Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Amneal Pharmaceuticals, Class
AMRX Stock  USD 8.27  0.08  0.96%   
Amneal Pharmaceuticals, financial statements provide useful quarterly and yearly information to potential Amneal Pharmaceuticals, Class investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Amneal Pharmaceuticals, financial statements helps investors assess Amneal Pharmaceuticals,'s valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Amneal Pharmaceuticals,'s valuation are summarized below:
Gross Profit
791.5 M
Profit Margin
(0.07)
Market Capitalization
3.9 B
Enterprise Value Revenue
1.915
Revenue
2.7 B
We have found one hundred twenty available fundamental signals for Amneal Pharmaceuticals, Class, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Amneal Pharmaceuticals, Class prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Enterprise Value is likely to rise to about 4.4 B in 2024, whereas Market Cap is likely to drop slightly above 695.5 M in 2024.

Amneal Pharmaceuticals, Total Revenue

1.73 Billion

Check Amneal Pharmaceuticals, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amneal Pharmaceuticals,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 154.9 M, Interest Expense of 119.8 M or Selling General Administrative of 281.2 M, as well as many indicators such as Price To Sales Ratio of 0.42, Dividend Yield of 0.096 or PTB Ratio of 56.75. Amneal financial statements analysis is a perfect complement when working with Amneal Pharmaceuticals, Valuation or Volatility modules.
  
Check out the analysis of Amneal Pharmaceuticals, Correlation against competitors.

Amneal Pharmaceuticals, Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.2 B3.5 B2.6 B
Slightly volatile
Common Stock Shares Outstanding151.5 M176.1 M120.8 M
Slightly volatile
Other Current Liabilities275.3 M475.4 M224.9 M
Slightly volatile
Total Current Liabilities589 M846.6 M440.2 M
Slightly volatile
Other Liabilities75 M111.7 M51.8 M
Slightly volatile
Property Plant And Equipment Net579.3 M550.1 M460.9 M
Slightly volatile
Accounts Payable222.4 M143.6 M159.4 M
Slightly volatile
Cash150.8 M91.5 M112.7 M
Slightly volatile
Non Current Assets Total2 B2.1 B1.4 B
Slightly volatile
Other Assets19.3 M20.3 M81.8 M
Slightly volatile
Long Term Debt2.2 B2.4 B1.5 B
Slightly volatile
Cash And Short Term Investments152 M91.5 M115 M
Slightly volatile
Net Receivables590.6 M613.7 M452.8 M
Slightly volatile
Good Will396.5 M598.6 M252.6 M
Slightly volatile
Short Term Investments1.9 M2.2 M3.2 M
Slightly volatile
Long Term Debt Total2.1 B3 B1.5 B
Slightly volatile
Non Current Liabilities Total2.5 B2.6 B1.8 B
Slightly volatile
Capital Surpluse648.3 M795.4 M578.6 M
Slightly volatile
Inventory454.1 M581.4 M356.3 M
Slightly volatile
Other Current Assets85.3 M91.2 M62.1 M
Slightly volatile
Total Liabilities3.1 B3.5 B2.3 B
Slightly volatile
Short and Long Term Debt223.8 M213.1 M53.6 M
Slightly volatile
Total Current Assets1.3 B1.4 B984.2 M
Slightly volatile
Short Term Debt239 M227.6 M59.5 M
Slightly volatile
Intangible Assets933.3 M890.4 M587.8 M
Slightly volatile
Common Stock3.2 M3.1 M2.8 M
Slightly volatile
Property Plant Equipment513.5 M540.3 M390.6 M
Slightly volatile
Short and Long Term Debt Total2.9 B2.8 B2.1 B
Slightly volatile
Current Deferred Revenue481.1 M458.2 M243.1 M
Slightly volatile
Common Stock Total Equity2.8 M3.5 M1.4 M
Slightly volatile
Liabilities And Stockholders Equity3.9 B3.5 B2.5 B
Slightly volatile
Capital Lease Obligations110 M109.9 M72.8 M
Slightly volatile
Net Invested Capital3 B2.7 B2 B
Slightly volatile
Property Plant And Equipment Gross712.1 M1.1 B576.7 M
Slightly volatile
Non Current Liabilities Other7.8 M8.2 M68.7 M
Slightly volatile
Net Working Capital750.4 M531.3 M590.1 M
Slightly volatile
Capital Stock3.3 M3.1 M3 M
Slightly volatile
Long Term Investments13.1 M14.7 M16 M
Slightly volatile
Warrants19.7 M28.7 M14.7 M
Slightly volatile

Amneal Pharmaceuticals, Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization154.9 M229.4 M109.6 M
Slightly volatile
Selling General Administrative281.2 M429.7 M211.7 M
Slightly volatile
Total Revenue1.7 B2.4 B1.4 B
Slightly volatile
Gross Profit675.9 M820.6 M574.6 M
Slightly volatile
Other Operating Expenses1.5 B2.2 B1.2 B
Slightly volatile
Research Development200.3 M167.8 M163.2 M
Slightly volatile
EBITDA334.5 M500.8 M289.9 M
Slightly volatile
Cost Of Revenue1 B1.6 B795.6 M
Slightly volatile
Total Operating Expenses481.7 M616.2 M388 M
Slightly volatile
Interest Income103.3 M199.1 M99.2 M
Slightly volatile
Reconciled Depreciation208.8 M229.4 M124 M
Slightly volatile
Extraordinary Items240 K180 K308 K
Slightly volatile
Preferred Stock And Other Adjustments645.6 K394.2 K891.7 K
Slightly volatile
Non Recurring348.6 M332 M129.5 M
Slightly volatile

Amneal Pharmaceuticals, Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow33.5 M35.2 M116.8 M
Slightly volatile
Depreciation154.9 M229.4 M109.6 M
Slightly volatile
Capital Expenditures72.7 M69.2 M86.6 M
Pretty Stable
Total Cash From Operating Activities203.5 M345.6 M166.8 M
Slightly volatile
End Period Cash Flow154.4 M99.1 M135.2 M
Pretty Stable
Change To Netincome170.7 M151.9 M117.2 M
Slightly volatile
Stock Based Compensation32.3 M26.8 M32.3 M
Pretty Stable
Cash Flows Other Operating217.5 M287.6 M183.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.420.44674.1618
Slightly volatile
Dividend Yield0.0960.09570.0829
Slightly volatile
Days Sales Outstanding13593.5877121
Pretty Stable
Operating Cash Flow Per Share1.081.9621.0678
Slightly volatile
Average Payables117.3 M134.9 M141.6 M
Slightly volatile
Stock Based Compensation To Revenue0.01060.01120.0654
Slightly volatile
Capex To Depreciation0.290.30162.2026
Slightly volatile
EV To Sales3.011.55754.9317
Slightly volatile
Inventory Turnover1.892.70572.0617
Slightly volatile
Days Of Inventory On Hand182135189
Slightly volatile
Payables Turnover6.9810.95657.4444
Slightly volatile
Sales General And Administrative To Revenue0.0960.120.122
Pretty Stable
Research And Ddevelopement To Revenue0.06660.07010.1265
Slightly volatile
Capex To Revenue0.02750.02890.0765
Slightly volatile
Cash Per Share0.780.53220.7585
Slightly volatile
POCF Ratio2.943.093858.6252
Pretty Stable
Capex To Operating Cash Flow0.190.20024.3955
Pretty Stable
Days Payables Outstanding48.8433.313753.0758
Slightly volatile
EV To Operating Cash Flow10.2510.7881167
Very volatile
Intangibles To Total Assets0.260.42880.2395
Slightly volatile
Current Ratio2.551.62752.4071
Slightly volatile
Receivables Turnover2.423.90013.0279
Pretty Stable
Graham Number1.041.09776.2386
Very volatile
Capex Per Share0.740.39280.6561
Pretty Stable
Revenue Per Share9.2213.58959.0524
Slightly volatile
Interest Debt Per Share13.116.187512.4792
Slightly volatile
Debt To Assets0.890.76040.8757
Slightly volatile
Short Term Coverage Ratios1.541.62153.2142
Pretty Stable
Operating Cycle317228310
Slightly volatile
Days Of Payables Outstanding48.8433.313753.0758
Slightly volatile
Price To Operating Cash Flows Ratio2.943.093858.6252
Pretty Stable
Long Term Debt To Capitalization1.120.99191.1054
Slightly volatile
Total Debt To Capitalization1.110.99261.095
Slightly volatile
Quick Ratio1.640.94081.5203
Slightly volatile
Dividend Paid And Capex Coverage Ratio5.244.99471.6691
Slightly volatile
Cash Ratio0.10.10810.2451
Pretty Stable
Cash Conversion Cycle268195257
Slightly volatile
Operating Cash Flow Sales Ratio0.130.14440.1291
Pretty Stable
Days Of Inventory Outstanding182135189
Slightly volatile
Days Of Sales Outstanding13593.5877121
Pretty Stable
Cash Flow Coverage Ratios0.10.13090.0969
Pretty Stable
Fixed Asset Turnover2.474.35092.9234
Slightly volatile
Capital Expenditure Coverage Ratio5.244.99472.3204
Slightly volatile
Price Cash Flow Ratio2.943.093858.6252
Pretty Stable
Debt Ratio0.890.76040.8757
Slightly volatile
Cash Flow To Debt Ratio0.10.13090.0969
Pretty Stable
Price Sales Ratio0.420.44674.1618
Slightly volatile
Asset Turnover0.680.68930.7025
Slightly volatile
Gross Profit Margin0.470.34280.4688
Slightly volatile

Amneal Pharmaceuticals, Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap695.5 M732.2 M3.8 B
Slightly volatile
Enterprise Value4.4 B3.7 B5.2 B
Slightly volatile

Amneal Fundamental Market Drivers

Forward Price Earnings6.2972
Cash And Short Term Investments91.5 M

Amneal Upcoming Events

7th of March 2024
Upcoming Quarterly Report
View
3rd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Amneal Pharmaceuticals, Financial Statements

Amneal Pharmaceuticals, investors use historical fundamental indicators, such as Amneal Pharmaceuticals,'s revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amneal Pharmaceuticals,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue458.2 M481.1 M
Total Revenue2.4 B1.7 B
Cost Of Revenue1.6 B1 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.12  0.10 
Research And Ddevelopement To Revenue 0.07  0.07 
Capex To Revenue 0.03  0.03 
Revenue Per Share 13.59  9.22 
Ebit Per Revenue 0.09  0.14 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Additional Tools for Amneal Stock Analysis

When running Amneal Pharmaceuticals,'s price analysis, check to measure Amneal Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals, is operating at the current time. Most of Amneal Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY